Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38α-activation

被引:41
作者
Ohkusu-Tsukada, K
Tominaga, N
Udono, H
Yui, K [1 ]
机构
[1] Nagasaki Univ, Div Immunol, Dept Translat Med Sci, Grad Sch Biomed Sci, 1-12-4 Sakamoto, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Div Med Virol, Dept Mol Microbiol & Immunol, Nagasaki 8528523, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528523, Japan
[4] RIKEN, Res Ctr Allergy & Immunol, Lab Immunochaperones, Yokohama, Kanagawa 2300045, Japan
关键词
D O I
10.1128/MCB.24.16.6957-6966.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In anergic T cells, T-cell receptor (TCR)-mediated responses are functionally inactivated by negative regulatory signals whose mechanisms are poorly understood. Here, we show that CD4(+) T cells anergized in vivo by superantigen Mls-1(a) express a scaffolding protein, transforming growth factor beta-activated protein kinase 1-binding protein 1 (TAB1), that negatively regulates TCR signaling through the activation of mitogen-activated protein kinase p38alpha. TAB1 was not expressed in naive and activated CD4(+) T cells. Inhibition of p38 activity in anergic T cells by a chemical inhibitor resulted in the recovery of interleukin 2 (IL-2) and the inhibition of IL-10 secretion. T-cell hybridoma 2B4 cells transduced with TAB1-containing retrovirus (TAB1-2B4 cells) showed activated p38alpha, inhibited extracellular signal-regulated kinase (ERK) activity, culminating in reduced IL-2 levels and increased IL-10 production. The use of a p38 inhibitor or cotransfection of a dominant-negative form of p38 in TAB1-2B4 cells resulted in the recovery of ERK activity and IL-2 production. These results imply that TAB1-mediated activation of p38alpha in anergic T cells regulates the maintenance of T-cell unresponsiveness both by inhibiting IL-2 production and by promoting IL-10 production.
引用
收藏
页码:6957 / 6966
页数:10
相关论文
共 49 条
[1]  
Akdis CA, 2000, FASEB J, V14, P1666
[2]   GRAIL:: An E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells [J].
Anandasabapathy, N ;
Ford, GS ;
Bloom, D ;
Holness, C ;
Paragas, V ;
Seroogy, C ;
Skrenta, H ;
Hollenhorst, M ;
Fathman, CG ;
Soares, L .
IMMUNITY, 2003, 18 (04) :535-547
[3]   Cutting edge: Cell autonomous rather than environmental factors control bacterial superantigen-induced T cell anergy in vivo [J].
Attinger, A ;
Acha-Orbea, H ;
MacDonald, HR .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1171-1174
[4]  
BHANDOOLA A, 1993, J IMMUNOL, V151, P2355
[5]   p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes [J].
Boussiotis, VA ;
Freeman, GJ ;
Taylor, PA ;
Berezovskaya, A ;
Grass, I ;
Blazar, BR ;
Nadler, LM .
NATURE MEDICINE, 2000, 6 (03) :290-297
[6]   Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rap1 [J].
Boussiotis, VA ;
Freeman, GJ ;
Berezovskaya, A ;
Barber, DL ;
Nadler, LM .
SCIENCE, 1997, 278 (5335) :124-128
[7]   A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages [J].
Brightbill, HD ;
Plevy, SE ;
Modlin, RL ;
Smale, ST .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1940-1951
[8]   Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo [J].
Buer, J ;
Lanoue, A ;
Franzke, A ;
Garcia, C ;
von Boehmer, H ;
Sarukhan, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (02) :177-183
[9]   Feedback control of the protein kinase TAK1 by SAPK2a/p38α [J].
Cheung, PCF ;
Campbell, DG ;
Nebreda, AR ;
Cohen, P .
EMBO JOURNAL, 2003, 22 (21) :5793-5805
[10]   Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways [J].
DeSilva, DR ;
Feeser, WS ;
Tancula, EJ ;
Scherle, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2017-2023